Trials Sponsors Conditions Drugs Pricing

Conditions

Neuromuscular Diseases Neuromuscular Diseases in Children Neuromuscular Disorder

Keywords

NeuromuscularResearch RepositoryBiobankNeuromuscular Disorder

Outcome Measures

Primary Outcomes (1)

To collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular disease are willing to donate.
Subjects will have the opportunity to provide the following samples: saliva or cheek swab, urine sample (up to 15ml), feces (up to 2mg of a stool sample), blood (up to 40ml), muscle biopsy tissue, and cell line (subjects have the option to allow a cell line to be made from their blood, muscle, or skin biopsies to provide a renewable supply of DNA and other cell components for research)
Baseline

Secondary Outcomes (1)

To collect medical history information from subjects with all types of neuromuscular disease and healthy controls.
Baseline

Eligibility Criteria

AgeUp to 75 Years

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

This is a very inclusive study that will allow samples from known subjects of sites' neuromuscular clinics, associated family members, and healthy volunteers. This study will include subjects with any form of neuromuscular disorder, including neuromuscular disorders of unknown etiology.

You may qualify if:

Willing and able to give informed consent

Sponsors & Collaborators

Virginia Commonwealth University
Otherlead

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

RECRUITING

Carino JenningsCONTACT804-828-1271 carino.garza@vcuhealth.org

Nicholas E. Johnson, MDPRINCIPAL INVESTIGATOR

Biospecimen

Retention: SAMPLES WITH DNA

As part of this repository, subjects will also have the option to allow a cell line to be made from their blood, muscle, or skin biopsies to provide a renewable supply of DNA and other cell components for research. A cell line is a frozen sample of specially processed cells from blood that allows us to grow more cells and obtain more DNA and other cell components, such as RNA or proteins, for future research. The cell line would not be labeled with the subjects name, address, birthdate, or other personal identifiers.

MeSH Terms

Conditions

Neuromuscular Diseases

Condition Hierarchy (Ancestors)

Nervous System Diseases

Study Officials

Nicholas E. Johnson, MD
Virginia Commonwealth University
PRINCIPAL INVESTIGATOR

Central Study Contacts

Nicholas Johnson

CONTACT

804-628-1624 nicholas.johnson@vcuhealth.org

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: CROSS SECTIONAL
Target Duration: 1 Day
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 21, 2022

First Posted

June 28, 2022

Study Start

March 17, 2021

Actual (reported)

Primary Completion

January 2030

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

CIMR Neuromuscular Research Biobank

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations